Expression of SPRY1 and SPRY2 is reduced in breast, prostate, lung and liver carcinoma, suggesting a tumor-suppressor role of SPRY in cancer.4 Role of SPRY in colorectal cancer (CRC) is still evolving. This evidence concerns the gene SPRY1 and colorectal carcinoma.